Keynote - Contraception Day Keynote: The Future of Female and Male Contraceptive and the NIH’s Role in the Development of New Contraceptive Methods
Time:2:45 pm - 3:30 pm
Location:HCC316 - Hawaii Convention Center
Diana Blithe, Ph.D., Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health
Supported by an educational grant from Merck
Needs Assessment and Description
Nearly half of all pregnancies in the United States are unintended, and discontinuation rates for existing methods are very high. The National Institute of Child Health and Human Development (NICHD) supports basic and clinical research to discover and develop new, safe, and effective contraceptive methods for men and women. Reproductive health professionals will learn about the products in the pipeline and potential targets for future contraceptive development.
At the conclusion of this session, participants should be able to:
- Summarize how hormonal contraception alters normal physiology.
- Evaluate evidence for communication between sperm and the oocyte complex.
- Identify potential targets for development of novel, safe, and effective methods of contraception for men and women.
A young nulliparous woman (age 18) is seeking an effective birth-control method. After participating in this session, in my practice based on typical use effectiveness rates, I will advise the following as the most effective methods for her:
a. Combined oral contraceptive pills (OCPs) and etonogestrel/ethinyl estradiol vaginal ring
b. Combined OCPs and intrauterine devices (IUDs)
c. Etonogestrel/ethinyl estradiol vaginal ring and IUDs
d. IUDs and progestin implants
e. Progestin implants and combined OCPs
f. Not applicable to my area of practice